Theranostics,
Год журнала:
2023,
Номер
13(3), С. 991 - 1009
Опубликована: Янв. 1, 2023
Background:
Complete
abolition
of
alveolar
epithelial
cells
(AECs)
is
characteristic
end-stage
lung
disease.Transplantation
therapy
type
II
AECs
(AEC-IIs)
or
AEC-IIs-derived
exosomes
(ADEs)
have
been
proposed
as
a
means
repairing
injury
and
preventing
fibrosis.However,
the
mechanism
by
which
ADEs
balances
airway
immunity
alleviates
damage
fibrosis
remains
unknown.Methods:
We
investigated
STIM-activating
enhancer-positive
(STIMATE
+
ADEs)
in
112
ALI/ARDS
44
IPF
patients,
observed
correlation
between
STIMATE
subpopulation
proportion
metabolic
status
tissue-resident
macrophages
(TRAMs).We
constructed
conditional
knockout
mice
sftpc
,
was
specifically
knocked
out
mouse
AEC-IIs
effects
deficiency
on
disease
progression,
immune
selection
switching
TRAMs.We
BLM-induced
model
to
observe
salvage
treatment
damage/fibrosis
progression
with
supplementation.Results:
In
clinical
analysis,
distinct
phenotypes
AMs
ALI/ARFS
were
significantly
perturbed
ADEs.The
TRAMs
lungs
imbalanced,
resulting
spontaneous
inflammatory
respiratory
disorders.STIMATE
are
taken
up
regulate
high
Ca
2+
responsiveness
long-term
signal
transduction,
maintains
M2-like
immunophenotype
metabolism
selection.This
involves
calcineurin
(CaN)-PGC-1α
pathway
mediated
mitochondrial
biogenesis
mtDNA
coding.In
bleomycin-induced
model,
supplementation
inhaled
lessened
early
acute
injury,
prevented
advanced
fibrosis,
alleviated
ventilatory
impairment
reduced
mortality.
Patients
with
progressive
fibrosing
interstitial
lung
diseases
(PF-ILDs)
carry
a
poor
prognosis
and
have
limited
therapeutic
options.
A
hallmark
feature
is
fibroblast
resistance
to
apoptosis,
leading
their
persistence,
accumulation,
excessive
deposition
of
extracellular
matrix.
complex
balance
the
B
cell
lymphoma
2
(BCL-2)
protein
family
controlling
intrinsic
pathway
apoptosis
reliance
on
antiapoptotic
proteins
has
been
hypothesized
contribute
this
resistant
phenotype.
Examination
tissue
from
patients
PF-ILD
(idiopathic
pulmonary
fibrosis
silicosis)
mice
(repetitive
bleomycin
showed
increased
expression
BCL-2
members
in
α–smooth
muscle
actin–positive
fibroblasts,
suggesting
that
fibroblasts
fibrotic
lungs
may
exhibit
susceptibility
inhibition
BCL-2,
BCL-XL,
BCL-W
BH3
mimetic
ABT-263.
We
used
murine
models
test
efficacy
ABT-263
reversing
established
persistent
fibrosis.
Treatment
induced
decreased
numbers,
reduced
collagen
levels,
radiographic
disease,
histologically
evident
Our
studies
provide
insight
into
how
gain
become
sensitive
proteins.
By
targeting
profibrotic
offers
promising
option
for
PF-ILDs.
Advances in respiratory medicine,
Год журнала:
2023,
Номер
91(1), С. 26 - 48
Опубликована: Янв. 31, 2023
The
respiratory
system
is
a
well-organized
multicellular
organ,
and
disruption
of
cellular
homeostasis
or
abnormal
tissue
repair
caused
by
genetic
deficiency
exposure
to
risk
factors
lead
life-threatening
pulmonary
disease
including
idiopathic
fibrosis
(IPF).
Although
there
no
clear
etiology
as
the
name
reflected,
its
pathological
progress
closely
related
uncoordinated
molecular
signals.
Here,
we
review
advances
in
our
understanding
role
lung
cells
IPF
pathology
epithelial
cells,
mesenchymal
stem
fibroblasts,
immune
endothelial
cells.
These
summarize
various
cell
components
signaling
pathways
pathogenesis
fibrosis,
which
helpful
further
study
mechanism
disease,
provide
new
opportunities
for
prevention
treatment,
expected
improve
survival
rate
quality
life
patients.
Advanced Drug Delivery Reviews,
Год журнала:
2024,
Номер
207, С. 115195 - 115195
Опубликована: Фев. 5, 2024
Enhanced
targeting
approaches
will
support
the
treatment
of
diseases
associated
with
dysfunctional
mitochondria,
which
play
critical
roles
in
energy
generation
and
cell
survival.
Obstacles
to
mitochondria-specific
include
presence
distinct
biological
barriers
need
pass
through
(or
avoid)
various
internalization
mechanisms.
A
range
studies
have
reported
design
mitochondrially-targeted
nanomedicines
that
navigate
complex
routes
required
influence
mitochondrial
function;
nonetheless,
a
significant
journey
lies
ahead
before
become
suitable
for
clinical
use.
Moving
swiftly
forward
require
safety
studies,
vivo
assays
confirming
effectiveness,
methodologies
validate
mitochondria-targeted
nanomedicines'
subcellular
location/activity.
From
nanomedicine
standpoint,
we
describe
involved
(from
administration
arrival
within
mitochondria),
features
influencing
rational
design,
techniques
used
identify/validate
successful
targeting.
Overall,
rationally-designed
mitochondria-targeted-based
hold
great
promise
precise
therapeutic
delivery.
Pharmacology & Therapeutics,
Год журнала:
2024,
Номер
262, С. 108710 - 108710
Опубликована: Авг. 22, 2024
In
an
aging
society,
unveiling
new
anti-aging
strategies
to
prevent
and
combat
aging-related
diseases
is
of
utmost
importance.
Mitochondria
are
the
primary
ATP
production
sites
key
regulators
programmed
cell
death.
Consequently,
these
highly
dynamic
organelles
play
a
central
role
in
maintaining
tissue
function,
mitochondrial
dysfunction
pivotal
factor
progressive
age-related
decline
cellular
homeostasis
organ
function.
The
current
review
examines
recent
advances
understanding
interplay
between
organ-specific
aging.
Thereby,
we
dissect
molecular
mechanisms
underlying
impairment
associated
with
deterioration
exploring
DNA,
reactive
oxygen
species
homeostasis,
metabolic
activity,
damage-associated
patterns,
biogenesis,
turnover,
dynamics.
We
also
highlight
emerging
therapeutic
preclinical
clinical
tests
that
supposed
rejuvenate
such
as
antioxidants,
biogenesis
stimulators,
modulators
turnover
Furthermore,
discuss
potential
benefits
challenges
use
interventions,
emphasizing
need
for
approaches
given
unique
characteristics
different
tissues.
conclusion,
this
highlights
addressing
mitigate
aging,
focusing
on
skin,
liver,
lung,
brain,
skeletal
muscle,
well
reproductive,
immune,
cardiovascular
systems.
Based
comprehensive
multifaceted
roles
mitochondria,
innovative
may
be
developed
optimized
biological
promote
healthy
across
diverse
Signal Transduction and Targeted Therapy,
Год журнала:
2025,
Номер
10(1)
Опубликована: Март 7, 2025
Redox
signaling
acts
as
a
critical
mediator
in
the
dynamic
interactions
between
organisms
and
their
external
environment,
profoundly
influencing
both
onset
progression
of
various
diseases.
Under
physiological
conditions,
oxidative
free
radicals
generated
by
mitochondrial
respiratory
chain,
endoplasmic
reticulum,
NADPH
oxidases
can
be
effectively
neutralized
NRF2-mediated
antioxidant
responses.
These
responses
elevate
synthesis
superoxide
dismutase
(SOD),
catalase,
well
key
molecules
like
nicotinamide
adenine
dinucleotide
phosphate
(NADPH)
glutathione
(GSH),
thereby
maintaining
cellular
redox
homeostasis.
Disruption
this
finely
tuned
equilibrium
is
closely
linked
to
pathogenesis
wide
range
Recent
advances
have
broadened
our
understanding
molecular
mechanisms
underpinning
dysregulation,
highlighting
pivotal
roles
genomic
instability,
epigenetic
modifications,
protein
degradation,
metabolic
reprogramming.
findings
provide
foundation
for
exploring
regulation
mechanistic
basis
improving
therapeutic
strategies.
While
antioxidant-based
therapies
shown
early
promise
conditions
where
stress
plays
primary
pathological
role,
efficacy
diseases
characterized
complex,
multifactorial
etiologies
remains
controversial.
A
deeper,
context-specific
signaling,
particularly
redox-sensitive
proteins,
designing
targeted
aimed
at
re-establishing
balance.
Emerging
small
molecule
inhibitors
that
target
specific
cysteine
residues
proteins
demonstrated
promising
preclinical
outcomes,
setting
stage
forthcoming
clinical
trials.
In
review,
we
summarize
current
intricate
relationship
disease
also
discuss
how
these
insights
leveraged
optimize
strategies
practice.
Oxidative Medicine and Cellular Longevity,
Год журнала:
2021,
Номер
2021(1)
Опубликована: Янв. 1, 2021
Mitochondria
are
indispensable
for
energy
metabolism
and
cell
signaling.
Mitochondrial
homeostasis
is
sustained
with
stabilization
of
mitochondrial
membrane
potential,
balance
calcium,
integrity
DNA,
timely
clearance
damaged
mitochondria
via
mitophagy.
dysfunction
featured
by
increased
generation
reactive
oxygen
species,
reduced
calcium
imbalance,
DNA
damage,
abnormal
Accumulating
evidence
indicates
that
dysregulation
causes
oxidative
stress,
inflammasome
activation,
apoptosis,
senescence,
metabolic
reprogramming.
All
these
cellular
processes
participate
in
the
pathogenesis
progression
chronic
respiratory
diseases,
including
obstructive
pulmonary
disease,
fibrosis,
asthma.
In
this
review,
we
provide
a
comprehensive
updated
overview
impact
on
involved
development
diseases.
This
not
only
implicates
mechanisms
lung
diseases
but
also
provides
potential
therapeutic
approaches
targeting
dysfunctional
mitochondria.
Mitochondrial
dysfunction
has
been
associated
with
age-related
diseases,
including
idiopathic
pulmonary
fibrosis
(IPF).
We
provide
evidence
that
implicates
chronic
elevation
of
the
mitochondrial
anion
carrier
protein,
uncoupling
protein-2
(UCP2),
in
increased
generation
reactive
oxygen
species,
altered
redox
state
and
cellular
bioenergetics,
impaired
fatty
acid
oxidation,
induction
myofibroblast
senescence.
This
pro-oxidant
senescence
reprogramming
occurs
concert
conventional
actions
UCP2
as
an
uncoupler
oxidative
phosphorylation
dissipation
membrane
potential.
is
highly
expressed
human
IPF
lung
myofibroblasts
aged
fibroblasts.
In
aging
murine
model
fibrosis,
vivo
silencing
induces
regression.
These
studies
indicate
a
pro-fibrotic
function
disease
support
its
therapeutic
targeting
diseases
tissue
regeneration
organ
fibrosis.